Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Jan 5, 2024
Date Accepted: Feb 13, 2025
Date Submitted to PubMed: Feb 19, 2025

The final, peer-reviewed published version of this preprint can be found here:

Assessing Health Information Seeking Behaviors Among Targeted Social Media Users Using an Infotainment Video About a Cancer Clinical Trial: Population-Based Descriptive Study

Sommers J, Dizon DS, Lewis MA, Stone E, Andreoli R, Henderson V

Assessing Health Information Seeking Behaviors Among Targeted Social Media Users Using an Infotainment Video About a Cancer Clinical Trial: Population-Based Descriptive Study

JMIR Cancer 2025;11:e56098

DOI: 10.2196/56098

PMID: 39970310

PMCID: 11892945

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Cancer Briefs: Evaluation of Infotainment on Social Media for Public Engagement about Cancer Clinical Trials

  • Jonathan Sommers; 
  • Don S Dizon; 
  • Mark A Lewis; 
  • Erik Stone; 
  • Richard Andreoli; 
  • Vida Henderson

ABSTRACT

Background:

Lack of information, awareness, and misconceptions about clinical trials are major barriers to cancer clinical trial participation. Digital and social media are dominant sources of health information and offer optimal opportunities to improve public medical awareness and education by providing accurate and trust-worthy sources of health information from reliable sources. Infotainment, material intended to both entertain and inform, is an effective strategy for engaging and educating audiences that can be easily disseminated using social media and may be a novel way to improve awareness about clinical trials.

Objective:

The purpose of this study was to evaluate whether infotainment videos, disseminated using social media, could drive health information seeking behaviors related to cancer clinical trials.

Methods:

We created the Cancer Briefs video series, which comprised 3 videos focused on immunotherapy and clinicals trials (video 1), promotion of a specific clinical trial (video 2), and diversity in clinical trials (video 3). We instituted a dissemination and marketing process to measure video engagement and health information seeking behaviors among public audiences on social media.

Results:

Even with a very modest marketing budget, the Cancer Briefs video series substantially increased health information seeking behavior by increasing research organization webpage visits by 873.8% (video 1), 41,300% (video 2), and 3,682.2% (video 3).

Conclusions:

Our study shows that digital and social media tools can be tailored for specific target audiences, are scalable, and can be disseminated at low cost, making it an accessible educational, recruitment, retention strategy focused on improving the conduct of clinical trials.


 Citation

Please cite as:

Sommers J, Dizon DS, Lewis MA, Stone E, Andreoli R, Henderson V

Assessing Health Information Seeking Behaviors Among Targeted Social Media Users Using an Infotainment Video About a Cancer Clinical Trial: Population-Based Descriptive Study

JMIR Cancer 2025;11:e56098

DOI: 10.2196/56098

PMID: 39970310

PMCID: 11892945

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.